Weight Loss Programme
0 Treatments
10 FAQs
Altibbi’s doctor-led weight management programme offers safe, structured, and clinically supervised support to help you reach your health goals. This 1-month plan includes four weekly injections, prescribed after a licensed medical consultation via our secure telehealth platform.
Following a brief online assessment, a qualified doctor will review your health profile and determine if a treatment plan is suitable. If approved, you will receive a customised dosing schedule, ongoing medical oversight, and discreet delivery to your doorstep.
This programme is designed for individuals seeking medical support as part of a broader weight loss and lifestyle journey.
All prescriptions are issued only after clinical review and may not be suitable for all patients. Treatment is subject to doctor approval and availability.
Treatments (0)
Advice for Weight Loss Programme
At Altibbi, we believe in accessible, evidence-based healthcare that empowers individuals to take control of their health. Our doctor-led weight loss programme is built on medical expertise, personalised care, and the convenience of modern telehealth.
Designed for adults with a higher body mass index (BMI), this programme offers professional guidance, ongoing support, and structured treatment plans tailored to your needs. Everything is managed online — from your initial consultation to prescription approval and doorstep delivery — with full confidentiality and regulatory compliance.
Whether you're looking to improve your health, manage weight long-term, or explore new medically reviewed options, Altibbi is here to support you every step of the way.
All treatment plans are subject to doctor review and approval. Suitability is assessed on a case-by-case basis.
Symptoms of Weight-Related Health Risks
Carrying excess weight is more than a cosmetic concern—it can lead to serious health complications. You may benefit from a medically guided weight loss programme if you experience:
-
Persistent weight gain despite lifestyle changes
-
Increased appetite or difficulty managing food portions
-
Fatigue or low energy levels
-
Shortness of breath during routine activity
-
Joint or back pain
-
Irregular blood sugar or cholesterol levels
-
Elevated blood pressure
-
Sleep disturbances, including sleep apnoea
-
Emotional distress or low self-esteem related to body image
These symptoms may indicate underlying metabolic conditions or hormonal imbalances that require professional medical assessment.
Why It Matters: Obesity in the UAE and Beyond
Obesity is a growing public health concern globally and within the UAE:
-
Over 70% of adults in the UAE are considered overweight or obese (World Obesity Federation, 2023)
-
Obesity significantly increases the risk of Type 2 diabetes, cardiovascular disease, and certain cancers
-
The UAE ranks among the top 5 Middle Eastern countries in obesity prevalence, according to WHO reports
Medical intervention, when combined with lifestyle modification, can result in significant improvements in long-term weight management and overall health.
Clinical Evidence Supporting Medical Weight Loss Approaches
Recent studies have shown that GLP-1 receptor-based therapies, when used as part of a structured programme, can:
-
Support sustained weight loss of 10–20% of body weight over 6–12 months
-
Improve glycaemic control and reduce cardiovascular risk markers
-
Help manage hunger, delay gastric emptying, and support behavioural change
Key studies include:
-
NEJM (2021): Once-weekly GLP-1 receptor agonist led to significant weight loss and improved cardiometabolic markers in adults with obesity
-
JAMA (2022): Participants achieved an average 15% body weight reduction over 68 weeks with guided medical and lifestyle therapy
-
Lancet (2022): Evidence supports GLP-1s as a safe and effective option for long-term obesity management
All treatment options provided by Altibbi are prescribed based on clinical need and individual assessment by a licensed doctor.
At Altibbi, every patient journey begins with a secure, medically reviewed consultation. As a DHA-approved telehealth provider, we follow all UAE federal healthcare regulations and data protection standards.
Your medical assessment is conducted 100% online by licensed physicians through encrypted, private channels. During this consultation, your doctor will evaluate your health profile, symptoms, lifestyle, and goals to determine whether medical weight management is clinically appropriate.
We ensure:
-
Confidentiality: All patient data is handled in accordance with UAE Federal Law No. 2 of 2019 on the Use of Information and Communications Technology (ICT) in Healthcare.
-
Medical Oversight: Only qualified doctors registered in the UAE will make clinical decisions regarding your treatment.
-
Compliance: All services are delivered under DHA regulations and in line with best practices in digital health.
Altibbi is committed to protecting your privacy while delivering high-quality, patient-centered care across the UAE.
Altibbi offers tailored weight management treatments as part of our doctor-led programme. If you are clinically eligible, your doctor may prescribe a plan that includes weekly injectable therapy supported by ongoing medical supervision.
We offer access to approved treatments such as:
-
Mounjaro® (tirzepatide)
-
Wegovy® (semaglutide)
These options are prescribed only after a full clinical consultation and are part of a broader medical weight loss strategy that may include nutritional guidance and regular follow-ups.
Our treatment plans include:
-
A clear, step-by-step dosing schedule
-
Monthly or quarterly supply options
-
Support from a licensed doctor throughout your journey
-
Discreet home delivery across the UAE
All medications are prescription-only and provided strictly under medical supervision. Treatment eligibility is determined by a qualified physician in line with UAE health regulations.
Weight Loss Programme FAQs (10)
Mounjaro® (tirzepatide) is a GLP-1 and GIP receptor agonist that helps regulate blood sugar and reduce appetite. It’s a once-weekly injection used to support weight loss and is prescribed only if clinically appropriate.
Yes. Mounjaro® is a prescription-only medication. You must complete an online consultation with a DHA-approved doctor through the Altibbi platform. The doctor will assess your eligibility and decide whether Mounjaro® is suitable for you.
Mounjaro® may be prescribed to adults with a BMI of 27 or above who have health conditions related to weight, such as insulin resistance or pre-diabetes. Final approval depends on medical history and clinical guidelines.
The entire process is online via secure telehealth. There’s no need to visit a clinic. Your doctor will review your case remotely and issue a prescription if you qualify.
It is a self-injectable pen taken once a week. If prescribed, you’ll receive detailed instructions and support on how to use it safely at home.
Weight loss results vary, but many patients start noticing changes within 4–8 weeks when combined with healthy lifestyle habits. The 3-month plan is designed to support steady, sustainable progress.
Yes. If prescribed, Mounjaro® will be shipped discreetly to your home anywhere in the UAE. Our pharmacy partners handle packaging and temperature control.
Some patients may experience mild nausea, constipation, or fatigue, especially during the first few weeks. These are typically manageable and temporary. Serious side effects are rare but will be explained during your consultation.
Possibly. Your doctor will evaluate your current treatment and goals. Switching between GLP-1 medications may be considered if clinically appropriate.
If Mounjaro® isn’t recommended, your doctor may suggest an alternative treatment plan. You’ll still receive medical guidance tailored to your needs.
